Top Ranked Momentum Stocks to Buy for July 21st

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 21st:

NIKE, Inc.


NKE

: This leading designer, marketer and distributor of authentic athletic footwear, apparel, equipment and accessories has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.

Nike’s shares gained 22.8% over the last one month compared to S&P 500’s rise of 1.5%. The company possesses a

Momentum Score

of B.

Lululemon Athletica Inc.


LULU

: This company that designs and retails athletic clothing for women, men, and female youth has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.

Lululemon Athletica’s shares gained 8.8% over the last one month. The company possesses a Momentum Score of B.

BHP Group


BHP

: This resources company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20% over the last 60 days.

BHP’s shares gained 4.8% over the last one month. The company possesses a Momentum Score of B.

ABB Ltd


ABB

: This company that manufactures and sells electrification, industrial automation, and robotics and motion products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

ABB’s shares gained 4.1% over the last one month. The company possesses a Momentum Score of B.

See the



full list of top ranked stocks here

Learn more about the



Momentum score and how it is calculated here



.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released

Century of Biology: 7 Biotech Stocks to Buy Right Now

to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research